Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

When artificial intelligence (AI) chip maker NVIDIA Corporation (NVDA) heads for the exit, investors instinctively glance at the door. In its latest 13F filing, the chip giant disclosed that it had ...

Ann Skeet is the Senior Director of Leadership Ethics at the Markkula Center of Applied Ethics. Views are her own. Ethical leadership creates an environment where the goals and values of people ...

Nvidia's positions in these companies were relatively small at the end of the third quarter of 2025, but the chipmaker has spent recent years building a portfolio of AI‑related investments across ...

The 2022 “Great American Race” winner turned a lap of 187.402 mph in his No. 2 Team Penske Ford. It’s the first of three scheduled practice sessions for Sunday’s 68th running of the Daytona 500 (1:30 ...

Practices at Lenovo Center are NOT open to the general public unless otherwise communicated. Practices at Invisalign Arena at Wake Competition Center ARE open to the public. No outside food or ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.